VICTORY CAPITAL MANAGEMENT INC

Position in FTRE — Fortrea Holdings Inc.

CIK 1040188 San Antonio, TX

Position in FTRE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,080,604

+$1,842,330 QoQ

Shares Held

220,871

+1499.0% QoQ

Ownership

0.233%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,018,555,898 across 156 Biotechnology names. FTRE ranks #53 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,888,521	$843,300,167
2	RPRX	Royalty Pharma plc	3,853,808	$184,867,169
3	INCY	Incyte Corp	1,742,870	$164,038,924
4	REGN	Regeneron Pharmaceuticals, Inc.	129,074	$99,727,735
5	ALNY	Alnylam Pharmaceuticals, Inc.	195,937	$64,829,675
6	INSM	INSMED Inc	396,245	$64,793,982
7	LGND	Ligand Pharmaceuticals Inc	303,224	$60,538,671
8	JAZZ	Jazz Pharmaceuticals plc	256,598	$48,509,851

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,080,604	220,871	+1499.0%	Shares	Sole	2026-05-15
2025-12-31	$238,274	13,813	+4.0%	Shares	Sole	2026-02-13
2025-09-30	$111,800	13,278	-96.5%	Shares	Sole	2025-11-12
2025-06-30	$1,869,641	378,470	+192.3%	Shares	Sole	2025-08-13
2025-03-31	$977,694	129,496	+615.1%	Shares	Sole	2025-05-02
2024-12-31	$337,714	18,108	-98.6%	Shares	Sole	2025-02-06
2024-09-30	$26,613,140	1,330,657	-46.0%	Shares	Sole	2024-11-05
2024-06-30	$57,560,664	2,466,181	+59.3%	Shares	Sole	2024-08-05
2024-03-31	$62,134,351	1,547,941	+224.6%	Shares	Sole	2024-05-03
2023-12-31	$16,644,682	476,925	-6.1%	Shares	Sole	2024-02-05
2023-09-30	$14,516,372	507,743	+383.7%	Shares	Sole	2023-11-06
2023-06-30	$3,570,029	104,970	—	Shares	Sole	2023-07-27
No filing history on record for this holder in this stock.